Jay Rubin

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease

David Wirta, Patrick Vollmer, James D. Paauw et al. · Ophthalmology · 2021 · 101 citations · Full text

Pharmacy, Ophthalmology, Pharmacotherapy +17

A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis11None of the investigators had a proprietary interest in loteprednol etabonate.

David G. Shulman, Larry L. Lothringer, Jay Rubin et al. · Ophthalmology · 1999 · 52 citations

Life Sciences, Pharmacology, Pharmacotherapy +12

Tear concentrations of levofloxacin following topical administration of a single dose of 0.5% levofloxacin ophthalmic solution in healthy volunteers

Michael B. Raizman, Jay Rubin, Adrienne Graves et al. · Clinical Therapeutics · 2002 · 40 citations

Medicine, Ophthalmology, Pharmacology +11

Perception and quality of life associated with the use of olopatadine 0.2% (Pataday™) in patients with active allergic conjunctivitis

Stephen V. Scoper, Gregg J. Berdy, Steven J. Lichtenstein et al. · Advances in Therapy · 2007 · 25 citations

Life Sciences, Ophthalmology, Pharmacotherapy +12